Nectar Lifesciences Board to consider final dividend

06 May 2013 Evaluate

Nectar Lifesciences has informed that a meeting of the Board of Directors of the Company will be held on May 15, 2013, to consider and approve the following: The Audited Financial Results for Financial Year 2012-13, Balance Sheet of the Company as at March 31, 2013 and Profit A Loss Accounts for the financial year ended on March 31, 2013 and matters related thereto, and recommendation of final dividend to the Members of the Company for Financial Year 2012-13.

The above information is a part of company’s filings submitted to BSE.

Nectar Lifesciences Share Price

20.95 0.01 (0.05%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×